(Q39922300)

15 September 2017

Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe (English)

1 reference

15 September 2017

1 reference

3

Björn Dahlöf

0 references

David Albert Jones

5

0 references

David Albert Jones

5

object named as

David Albert Jones

1 reference

15 September 2017

Atholl Johnston

1

1 reference

15 September 2017

Roland Asmar

2

1 reference

15 September 2017

Kate Hill

4

1 reference

15 September 2017

Jens Jordan

6

1 reference

15 September 2017

Michael Livingston

7

1 reference

15 September 2017

Graham Macgregor

8

1 reference

15 September 2017

Michael Sobanja

9

1 reference

15 September 2017

Panagiotis Stafylas

10

1 reference

15 September 2017

Enrico Agabiti Rosei

11

1 reference

15 September 2017

José Zamorano

12

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

British Journal of Clinical Pharmacology

15 September 2017

1 reference

15 September 2017

72

1 reference

15 September 2017

5

1 reference

15 September 2017

727-730

1 reference

Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243005

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243005

An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243005

Cost of switching hypertensive patients from enalapril maleate to lisinopril.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243005

Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243005

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243005

Comparison of Steady-State Serum Concentrations of Digoxin in Tablets (Lanoxin) and Capsules (Lanoxicaps) in the Elderly

20 August 2018

1 reference

12 December 2020

"Inactive" excipients such as Cremophor can affect in vivo drug disposition

1 reference

12 December 2020

Differences in serum concentrations of and responses to generic verapamil in the elderly

1 reference

12 December 2020

Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid

1 reference

12 December 2020

Three generations of cyclosporine a formulations: an in vitro comparison

1 reference

12 December 2020

10.1111/J.1365-2125.2011.03987.X

Identifiers

DOI

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

21486316

1 reference